基因名称：ASXL3 （ASXL transcriptional regulator 3）
别名： BRPS,KIAA1713
基因ID：80816
Chromosome(GRCh37) ：18 Start: 31158541 End: 31331159 Strand:
信号通路：
靶向药：
化疗药：
简介：该基因编码一种含有植物同源结构域（phd）锌指结构域的蛋白质，该结构域在基因转录调控中起作用。编码蛋白通过结合和抑制两种核激素受体（oxysterols receptor LXR alpha（LXRalpha））和甲状腺激素受体β（TRbeta））的转录活性而负性调节脂肪生成所编码的蛋白质也可能抑制组蛋白的脱氨作用在人类贝氏综合征（bainbridge-ropers syndrome，bainbridge-ropers syndrome）患者中发现了该基因的突变，其特征是进食困难、发育迟缓等。[由RefSeq提供，2017年5月]This gene encodes a protein containing a plant homeodomain (PHD) zinc finger domain that plays a role in the regulation of gene transcription. The encoded protein has been shown to negatively regulate lipogenesis by binding to and inhibiting the transcriptional activity of two nuclear hormone receptors, oxysterols receptor LXR-alpha (LXRalpha) and thyroid hormone receptor beta (TRbeta). The encoded protein may also inhibit histone deubiquitination. Mutations in this gene have been identified in human patients with Bainbridge-Ropers syndrome, which is characterized by feeding difficulties, developmental delay and other features. [provided by RefSeq, May 2017]
ASXL3突变与药物：
